FDA Inspection 1100819 — Fareva Amboise
The FDA completed an inspection of Fareva Amboise on Dec 13, 2018 in Poce Sur Cisse. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 13, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Poce Sur Cisse (France)
Additional Details
Mutual Recognition Agreement (MRA)